| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/26/2012 | CA2809045A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | CA2806310A1 Methods of detecting diseases or conditions using phagocytic cells |
| 01/26/2012 | CA2806306A1 Co-coupling to control reactivity of reagents in immunoassays |
| 01/26/2012 | CA2806304A1 Methods of detecting prenatal or pregnancy-related diseases or conditions |
| 01/26/2012 | CA2806302A1 Methods of detecting neurological or neuropsychiatric diseases or conditions |
| 01/26/2012 | CA2806301A1 Methods of detecting cardiovascular diseases or conditions |
| 01/26/2012 | CA2806296A1 Methods of detecting kidney-associated diseases or conditions |
| 01/26/2012 | CA2806293A1 Methods of detecting autoimmune or immune-related diseases or conditions |
| 01/26/2012 | CA2806291A1 Methods for detecting signatures of disease or conditions in bodily fluids |
| 01/26/2012 | CA2806211A1 Mass spectrometric methods for quantifying npy 1-36 and npy 3-36 |
| 01/26/2012 | CA2806127A1 Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| 01/26/2012 | CA2806076A1 Anti-tumor antigen antibodies and methods of use |
| 01/26/2012 | CA2806067A1 Automated analysis of pressurized reservoir fluids |
| 01/26/2012 | CA2806025A1 Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
| 01/26/2012 | CA2805794A1 Signal biomarkers |
| 01/26/2012 | CA2805754A1 Chemical and physical degradation sensing in oil |
| 01/26/2012 | CA2805709A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/26/2012 | CA2805708A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/26/2012 | CA2805658A1 Combination therapy with mdm2 and efgr inhibitors |
| 01/26/2012 | CA2805623A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/26/2012 | CA2805622A1 Method for hydrophilizing surfaces of fluidic components and parts containing such components |
| 01/26/2012 | CA2805618A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/26/2012 | CA2805524A1 Sound-velocity dewatering system |
| 01/26/2012 | CA2805486A1 Method for linking point of care rapid diagnostic testing results to laboratory-based methods |
| 01/26/2012 | CA2805076A1 Detector arrangement for blood culture bottles with colorimetric sensors |
| 01/26/2012 | CA2804507A1 Biosensor apparatuses and methods thereof |
| 01/26/2012 | CA2804350A1 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
| 01/26/2012 | CA2804348A1 Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancer |
| 01/26/2012 | CA2804246A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/26/2012 | CA2803610A1 Apparatus, system, and method for increasing measurement accuracy in a particle imaging device using light distribution |
| 01/26/2012 | CA2802111A1 Identification of differentially represented fetal or maternal genomic regions and uses thereof |
| 01/25/2012 | EP2410449A2 Information communication system |
| 01/25/2012 | EP2410341A1 Analysis chip, analysis method and method for stirring solution |
| 01/25/2012 | EP2410339A1 Method for the detection of acid production by cariogenic bacteria |
| 01/25/2012 | EP2410338A1 Method for the detection of acid production by cariogenic bacteria |
| 01/25/2012 | EP2410337A1 Method for measuring -glucan, and -glucan-binding protein for use in the method |
| 01/25/2012 | EP2410336A1 Diagnostic marker for breast cancer, having thioredoxin-1 as an active ingredient, and diagnostic kit for breast cancer using same |
| 01/25/2012 | EP2410335A1 Pathogen detection biosensor |
| 01/25/2012 | EP2410334A1 T-lymphocyte mitogen for use in a skin test |
| 01/25/2012 | EP2410333A1 Method of detecting target, method of suppressing increase in background and detection apparatus |
| 01/25/2012 | EP2410332A1 Method for identifying purinergic modulators of the olfactory system |
| 01/25/2012 | EP2410331A1 Aminoacyl-tRNA synthetase for aminoacylation tRNA with unnatural amino acids |
| 01/25/2012 | EP2410330A2 Methods of using GPR119 receptor to identify compounds useful for increasing bone mass in an individual |
| 01/25/2012 | EP2410329A1 Composition for plasma and serum separation, and container for blood testing |
| 01/25/2012 | EP2410328A1 Method for tracking a piece of wood |
| 01/25/2012 | EP2410327A1 Device for detecting pollutants in a fluid medium, in particular hydrocarbons or organic compounds in an aqueous medium |
| 01/25/2012 | EP2410326A2 Exhaust gas analyzing system |
| 01/25/2012 | EP2410325A1 Apparatus and methods for polymer characterization |
| 01/25/2012 | EP2410321A1 Water analysis sensor electrode |
| 01/25/2012 | EP2410316A1 Textile material measuring device and yarn winding machine |
| 01/25/2012 | EP2410314A2 Method and apparatus for sorting cells |
| 01/25/2012 | EP2410063A1 Method, kit and device for detecting nucleic acid |
| 01/25/2012 | EP2410062A1 Selectivity profiling of PI3K interacting molecules against multiple targets |
| 01/25/2012 | EP2410050A1 Fertility test method, fertility test kit, polynucleotide, polypeptide and antibody |
| 01/25/2012 | EP2410045A1 A method for testing an immune response |
| 01/25/2012 | EP2409767A1 Modular cartridge, system and method for automated medical diagnosis |
| 01/25/2012 | EP2409766A1 Method for hydrophilising surfaces of fluid components and objects containing such components |
| 01/25/2012 | EP2409732A1 Compositions and methods for bone formation and remodeling |
| 01/25/2012 | EP2409711A1 Enzyme treatment of foodstuffs for celiac sprue |
| 01/25/2012 | EP2409644A1 Combined lancet and electrochemical analyte-testing apparatus |
| 01/25/2012 | EP2409157A2 Citrulline, a risk indicator for cardiovascular disease |
| 01/25/2012 | EP2409156A2 Akt tyrosine 176 phosphorylation cancer biomarker |
| 01/25/2012 | EP2409155A1 Soluble hla complexes for use in disease diagnosis |
| 01/25/2012 | EP2409154A1 Non-invasive method for assessing liver fibrosis progression |
| 01/25/2012 | EP2409153A2 Mass-sensitive sensor comprising immobilised cells on its surface and method of detecting ligand binding making use of the sensor |
| 01/25/2012 | EP2409152A1 Methods for modulating circadian rythms |
| 01/25/2012 | EP2409151A2 Device for capturing circulating cells |
| 01/25/2012 | EP2409150A1 Addressable antibody arrays and methods of use |
| 01/25/2012 | EP2409149A1 Methods of screening using amphibians |
| 01/25/2012 | EP2409148A1 Exhaled breath condensate biometric marker measurement apparatus and method |
| 01/25/2012 | EP2409147A1 Use of hydrophobic dyes to monitor hydrophobic contaminants in a papermaking process |
| 01/25/2012 | EP2409146A2 Method and device for determining a foreign substance content in a matrix |
| 01/25/2012 | EP2409139A2 Non-coherent light microscopy |
| 01/25/2012 | EP2409136A1 Device and method for optical sensing of substances or environmental conditions |
| 01/25/2012 | EP2409131A1 High throughput, seed sampling and collection system and method |
| 01/25/2012 | EP2408936A2 Use of thermostable endonucleases for generating reporter molecules |
| 01/25/2012 | EP2408931A2 Test element for determining a body fluid and measurement method |
| 01/25/2012 | EP2408928A1 Method for detection of an enzyme-substrate reaction |
| 01/25/2012 | EP2408927A1 Probe compound for detecting and isolating enzymes and means and methods using the same |
| 01/25/2012 | EP2408905A2 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| 01/25/2012 | EP2408899A1 Devices for separating cells and methods of using them |
| 01/25/2012 | EP2408819A2 High affinity t-cell receptor-like ny-eso-1 peptide antibodies, methods, and uses thereof |
| 01/25/2012 | EP2408803A1 Inhibitors of viral integrase and methods of use |
| 01/25/2012 | EP2408786A1 Novel silane compounds having a cyclic carbon chain including an alkyne function for functionalising solid substrates and immobilising biological molecules on said substrates |
| 01/25/2012 | EP2408471A1 Targets for growth factor signalling and methods of therapy |
| 01/25/2012 | EP2408368A1 Method of continuously measuring substrate concentration |
| 01/25/2012 | EP2281046B1 LUCIFERASE BIOSENSORS FOR cAMP |
| 01/25/2012 | EP2069791B1 Cellular receptor for antiproliferative factor |
| 01/25/2012 | EP2069561B1 Device for a textile machine for measuring the length-specific mass and/or the moisture of a strand-shaped, continuous fiber batch, and textile machine |
| 01/25/2012 | EP2069395B1 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
| 01/25/2012 | EP2052247B1 Method and apparatus for acoustically testing wooden poles |
| 01/25/2012 | EP2034017B1 Gene involved in immortalization of human cancer cell and use thereof |
| 01/25/2012 | EP2019658B1 Method of microfluidic membraneless exchange in an h-filter and filtration of the extraction fluid outlet streams |
| 01/25/2012 | EP1813946B1 Biomaterial structure, method of producing the same and uses thereof |
| 01/25/2012 | EP1779109B1 Sensor array |
| 01/25/2012 | EP1759190B1 Physical quantity, particularly humidity detection device, and related detecting method |
| 01/25/2012 | EP1746928B1 Optical sensor for in vivo detection of analyte |
| 01/25/2012 | EP1624753B1 Purinergic modulation of smell |
| 01/25/2012 | EP1613659B1 New monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 01/25/2012 | EP1550462B1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |